EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Folic acid inhibits 5‐methyltetrahydrofolate transport across the blood–cerebrospinal fluid barrier: Clinical biochemical data from two cases

Tomoyuki Akiyama iD, Ichiro Kuki, Kiyohiro Kim, Naohiro Yamamoto, Yumi Yamada, Kazuya Igarashi, Tomohiko Ishihara, Yuya Hatano, Katsuhiro Kobayashi

JIMD Reports · 2022-11 · 63 (6) · 529-535

DOI: 10.1002/jmd2.12321 ↗

Kurz gefasst

Fallbericht in der Zeitschrift JIMD Reports, online erschienen am 06.08.2022. Verfasst von Tomoyuki Akiyama und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child Neurology Okayama University Hospital Okayama Japan. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Ministry of Health, Labour and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The use of folic acid (FA) has been discouraged in cerebral folate deficiency (CFD) because, theoretically, it could inhibit the transport of 5‐methyltetrahydrofolic acid (5MTHF) across the blood–cerebrospinal fluid (CSF) barrier. We present the clinical biochemical data of two cases with CFD to support this hypothesis.

Methods

We measured CSF and serum 5MTHF concentrations in a patient with Kearns‐Sayre syndrome (KSS) and a patient homozygous for MTHFR C677T polymorphism before and during folate supplementation therapy. To evaluate these 5MTHF concentrations, we also analyzed CSF and serum samples in pediatric patients without folate supplementation.

Results

Both patients had low CSF 5MTHF before treatment and high‐dose FA therapy did not normalize CSF 5MTHF. There was a dissociation between serum total folate and 5MTHF concentrations during FA therapy, which was considered to be due to the appearance of unmetabolized FA. The addition of folinic acid did not improve low CSF 5MTHF in the KSS patient and the cessation of FA resulted in the normalization of CSF 5MTHF. In the patient homozygous for MTHFR C677T, minimization of the FA dosage resulted in the normalization of CSF 5MTHF and an increased CSF‐to‐serum 5MTHF ratio.

Conclusions

Our data suggest that excess supplementation of FA impaired 5MTHF transport across the blood–CSF barrier. In the treatment of CFD, supplementation of folinic acid or 5MTHF (in cases of impaired 5MTHF synthesis) is preferred over the use of FA. The reference values of CSF 5MTHF concentration based on 600 pediatric cases were also provided.

Schlagwörter

Stichwörter der Autor:innen

5‐formyltetrahydrofolic acidKearns‐Sayre syndromecerebral folate deficiencyfolate receptor 1folinic acidmethylenetetrahydrofolate reductase deficiency

Autor:innen und Institutionen

  • Department of Child Neurology Okayama University Hospital Okayama Japan.
  • Department of Child Neurology, Okayama University Graduate School of Medicine Dentistry and Pharmaceutical Sciences Okayama Japan.
  • Department of Pediatric Neurology Osaka City General Hospital Osaka Japan.
  • Department of Pediatric Neurology Hyogo Prefectural Amagasaki General Medical Center Hyogo Japan.
  • Department of Neurology National Hospital Organization Nishiniigata Chuo Hospital Niigata Japan.
  • Department of Neurology, Brain Research Institute Niigata University Niigata Japan.

ORCID-Profile: Tomoyuki Akiyama

Förderung

  • Japan Society for the Promotion of Science
  • Ministry of Health, Labour and Welfare

Zitieren

APA

Akiyama, T., Kuki, I., Kim, K., Yamamoto, N., Yamada, Y., Igarashi, K., Ishihara, T., Hatano, Y., & Kobayashi, K. (2022). Folic acid inhibits 5‐methyltetrahydrofolate transport across the blood–cerebrospinal fluid barrier: Clinical biochemical data from two cases. JIMD Reports, 63(6), 529-535. https://doi.org/10.1002/jmd2.12321

Vancouver

Akiyama T, Kuki I, Kim K, Yamamoto N, Yamada Y, Igarashi K, et al. Folic acid inhibits 5‐methyltetrahydrofolate transport across the blood–cerebrospinal fluid barrier: Clinical biochemical data from two cases. JIMD Reports. 2022;63(6):529-535. doi:10.1002/jmd2.12321

BibTeX
@article{Akiyama2022,
  author = {Akiyama, Tomoyuki and Kuki, Ichiro and Kim, Kiyohiro and Yamamoto, Naohiro and Yamada, Yumi and Igarashi, Kazuya and Ishihara, Tomohiko and Hatano, Yuya and Kobayashi, Katsuhiro},
  title = {Folic acid inhibits 5‐methyltetrahydrofolate transport across the blood–cerebrospinal fluid barrier: Clinical biochemical data from two cases},
  journal = {JIMD Reports},
  year = {2022},
  volume = {63},
  number = {6},
  pages = {529--535},
  doi = {10.1002/jmd2.12321}
}
Kostenlos starten →